PHAT Q1 2025 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+1391.6% YoY

Gross Profit

$25M86.9% margin

Operating Income

-$79M-276.5% margin

Net Income

-$94M-330.7% margin

EPS (Diluted)

$-1.31

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$85M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$294M

Total Liabilities

$633M

Stockholders' Equity

-$338M

Cash & Equivalents

$212M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$2M	+1391.6%
Gross Profit	$25M	$1M	+1568.6%
Operating Income	-$79M	-$70M	-12.7%
Net Income	-$94M	-$83M	-13.8%